Northern Trust Corp Windtree Therapeutics Inc Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $1.14 $1,602 - $4,808	-4,218 Reduced 7.75%	50,176 $21,000
Q1 2022 May 13, 2022	SELL	$0.94 - $1.6 $15,270 - $25,992	-16,245 Reduced 23.0%	54,394 $62,000
Q4 2021 Feb 08, 2022	SELL	$1.4 - $2.31 $1,384 - $2,284	-989 Reduced 1.38%	70,639 $114,000
Q3 2021 Nov 15, 2021	BUY	$1.66 - $2.27 $10,371 - $14,182	6,248 Added 9.56%	71,628 $148,000
Q2 2021 Aug 13, 2021	BUY	$1.68 - $2.79 $24,590 - $40,837	14,637 Added 28.85%	65,380 $149,000
Q1 2021 May 12, 2021	SELL	$2.14 - $6.18 $46,313 - $133,747	-21,642 Reduced 29.9%	50,743 $125,000
Q4 2020 Feb 11, 2021	SELL	$4.98 - $7.47 $45,845 - $68,768	-9,206 Reduced 11.28%	72,385 $371,000
Q3 2020 Nov 16, 2020	BUY	$5.5 - $9.9 $103,961 - $187,129	18,902 Added 30.15%	81,591 $449,000
Q2 2020 Aug 14, 2020	BUY	$3.3 - $9.96 $206,873 - $624,382	62,689 New	62,689 $439,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $34M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.